Inventor

David Francis Alain Lançois

Inventor
Louviers, FR

Overview

26→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes21%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
11,084,826RSV antiviral pyrazolo- and triazolo-pyrimidine compounds202110,611,769RSV antiviral pyrazolo- and triazolo-pyrimidine compounds202010,526,338Functionalized pentanoic acids for use influenza viral infections202010,526,331Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones202010,501,463Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones201910,208,048RSV antiviral pyrazolo- and triazolo-pyrimidine compounds201910,155,759Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones201810,150,761Substituted pyridine-piperazinyl analogues as RSV antiviral compounds20189,884,864'Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones'20189,617,262'Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20179,617,244'Antibacterial quinoline derivatives'20179,598,407'Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20179,394,295'Antibacterial homopiperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20169,315,522'Antibacterial compounds'20169,296,760'Antibacterial compounds'20169,290,493'Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20169,133,167'Antibacterial quinoline derivatives'20159,012,634'Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20158,906,923'Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones'20148,841,321'Quinoline derivatives as antibacterial agents'20148,802,671'Quinoline derivatives as antibacterial agents'20148,415,475'Antibacterial quinoline derivatives'20138,017,606'Quinoline derivatives as antibacterial agents'20117,915,292'Antibacterial quinoline derivatives'20117,902,225'Mycobacterial inhibitors'20117,790,894'Mycobacterial inhibitors'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2017Patents assigned to JANSSEN PHARMACEUTICA NV (9)· patent assignee history
2010–2020Based in Louviers, FR· patent location history
2011Based in Le Neubourg, FR· patent location history
2013–2016Patents assigned to KOUL ANIL (6)· patent assignee history
2014–2016Patents assigned to LANÇOIS DAVID FRANCIS ALAIN (5)· patent assignee history
2015–2017Based in Val de Reuil, FR· patent location history
2016–2020Patents assigned to JANSSEN SCIENCES IRELAND UC (11)· patent assignee history
2019–2021Patents assigned to JANSSEN SCIENCES IRELAND UNLIMITED CO (4)· patent assignee history
2019–2021Based in Issy les Moulineaux, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN SCIENCES IRELAND UC112016–2020
JANSSEN PHARMACEUTICA NV92010–2017
KOUL ANIL62013–2016
LANÇOIS DAVID FRANCIS ALAINself52014–2016
JANSSEN SCIENCES IRELAND UNLIMITED CO42019–2021
Locations
LocationPatentsSpan
Louviers, FR202010–2020
Issy les Moulineaux, FR32019–2021
Val de Reuil, FR22015–2017
Le Neubourg, FR12011